MedTrace Logo

A Clinical Trial of Magnetic Stimulation in Depression

NCT00711568 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2013-04-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether repetitive high field transcranial magnetic stimulation of the left or right frontal lobes is beneficial for the treatment of depression that is refractory to antidepressant medication.

Conditions

Interventions

PROCEDURE

Repetitive transcranial magnetic stimulation (rTMS)

20 Hz rTMS delivered for 2 seconds (40 stimuli) every 30 seconds for a total of 2000 stimuli (25 minutes)

PROCEDURE

Sham rTMS

20 Hz sham rTMS delivered to L or R frontal region for 2 seconds (40 stimuli) every 30 seconds for a total of 2000 stimuli

DEVICE

Repetitive Transcranial Magnetic Stimulator

Repetitive Transcranial Magnetic Stimulator

Sponsors & Collaborators

Principal Investigators

  • Stephen E. Nadeau, MD BS BS · North Florida/South Georgia Veterans Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2007-08-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00711568 on ClinicalTrials.gov